Licensing Pharmacy Webinar 
Drug Channels
FEBRUARY 26, 2025
Pharmacies and Pharmacy Benefit Managers. Email Paula Fein ( paula@drugchannels.net ) if youd like to bundle the report purchase with access to DCIs video webinars. On March 18, 2025, Drug Channels Institute will release The 2025 Economic Report on U.S. drug pricing, reimbursement, and dispensing system.
Drug Channels
MARCH 19, 2024
Pharmacies and Pharmacy Benefit Managers , available for purchase and immediate download. Pharmacies and Pharmacy Benefit Managers’ (press release) Review pricing/license options and download the full 2024 report We’re offering special discounted pricing if you order before April 8, 2024.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Channels
MARCH 7, 2024
Pharmacies and Pharmacy Benefit Managers. Review pricing/license options and place a preorder. Email Paula Fein ( paula@drugchannels.net ) if you’d like to bundle the report purchase with access to DCI’s video webinars. On March 19, 2024, Drug Channels Institute will release The 2024 Economic Report on U.S.
Policy Prescription
MAY 28, 2021
NeedyMeds , a non-profit organization known for providing patients with help in finding pharmaceutical company-sponsored prescription assistance programs and other drug savings options, hosted a webinar about drug importation last year called “ Drug Importation: The topic everyone’s talking about.” The featured speaker was, Shabbir J.
Fierce BioTech
MARCH 29, 2024
Is your pharmacy ready to make the leap? Is your pharmacy ready to make the leap? Listing Image Inovalon Logo.png Listing Introduction Pharmacists are being called to operate at the top of their license to close gaps in care. Learn how your pharmacy can prepare today for a future of pharmacy focused on patient outcomes.
Agency IQ
OCTOBER 27, 2023
and Annex 1 Conference Joel Welch December 18 RAPS RAPS Webcast: FDA Forecast: What’s Next for the FDA in 2024 AgencyIQ Speakers December 21 HL7 REMS Public Call PDUFA Dates expected in November and December PDUFA dates represent the expected date of a regulatory decision by the FDA on a New Drug Application or Biologics License Application.
Agency IQ
SEPTEMBER 29, 2023
Based on the results of its evaluation of nominated categories of drug products to date, as well as consultation with the Pharmacy Compounding Advisory Committee (PCAC), FDA is also proposing to include certain categories of drug products on these lists. The rule, will also, if finalized, address communication with State boards of pharmacy.
Expert insights. Personalized for you.
98 
Let's personalize your content